Fertility Test Market Size and Share Forecast Outlook From 2024 to 2034
The Fertility Test Market size is expected to develop at a CAGR of 7.9% during the projected period. The growing awareness about infertility and the need for early detection is increasing the sales of fertility test kits. As a result, the market value is projected to increase from USD 548.4 million in 2024 to USD 1.2 billion by 2034.
Fertility Test Market Insights and Analysis
- Many couples today are choosing to delay parenthood until later in life, which can increase the risk of infertility. Consequently, more people are seeking fertility tests to determine their chances of conception and take proactive steps to address any issues.
- There is a rise in the number of people seeking assisted reproductive technologies (ART). These include procedures like in vitro fertilization (IVF), which can be costly and require significant planning and preparation. Fertility tests can help couples determine if ART is a viable option for them and improve their chances of success.
- Advancements in technology have also played a significant role in the growth of the fertility test market. The development of more accurate and reliable tests has made it easier for couples to get a clearer picture of their fertility status. For example, home fertility test kits that use saliva or urine samples are now widely available and can provide results within minutes.
- With many people staying at home during and after the Covid-19 pandemic, there has been a rise in the use of at-home fertility tests. These tests allow people to monitor their fertility from the comfort of their own homes without the need for a doctor's visit.
| Attributes |
Details |
| Estimated Market Size in 2024 |
USD 548.4 million |
| Forecasted Market Size by 2034 |
USD 1.2 billion |
| Projected Value CAGR (2024 to 2034) |
7.9% |
Factors Restraining the Demand for Fertility Testing Solutions
- The lack of awareness among potential consumers about the importance of fertility testing is a significant issue. Many people are unaware of the various fertility testing options available to them and the benefits of undergoing such tests. This lack of awareness has resulted in a relatively low demand for fertility testing services, which in turn affects the market's growth.
- The high cost of fertility testing services limits their adoption. Most fertility testing procedures are expensive and are often not covered by insurance. This cost can discourage potential consumers from seeking fertility testing, further hindering the market's growth.
- The market is highly competitive, with a large number of players offering similar products and services. This competition makes it difficult for new entrants to establish themselves in the market and gain market share. Established players have an advantage in terms of brand recognition and customer loyalty, making it challenging for new entrants to compete.
Emerging Opportunities in the Fertility Test Market
The demand for home-based fertility testing kits is on the rise. These kits are cost-effective and offer convenience to users, making them an attractive option for those who prefer to assess their fertility levels in the privacy of their homes.
As a result, many companies are focusing on developing innovative and accurate home-based testing kits to meet this demand.
The rise of digital health technology is also creating new opportunities for market players in the fertility testing market. Mobile apps, wearables, and other digital health tools are gaining popularity among consumers. Many companies are developing fertility testing products that can be integrated with these tools.
This integration allows for a more personalized approach to fertility testing, potentially leading to better outcomes for users. Companies that can develop innovative and accurate fertility testing products catering to these trends are likely to be well-positioned for success in this market.
Fertility Test Industry Analysis by Top Investment Segments
The ovulation prediction kit segment dominates the market by product and is projected to maintain its dominance through 2034, registering a 7.7% CAGR. The saliva segment leads the market in terms of the sample category. This segment is expected to record a CAGR of 7.4% during the forecast period.
Ovulation Prediction Kit Segment Holds Firm Grip on the Market
| Attributes |
Details |
| Product |
Ovulation prediction kit |
| Forecasted CAGR From 2024 to 2034 |
7.7% |
The market is significantly influenced by the dominance of the ovulation prediction kit segment, supported by the following points:
- Ovulation prediction kits are designed to detect the surge of luteinizing hormone (LH), which occurs 24-36 hours before ovulation. This feature makes them highly accurate in predicting the most fertile days in a woman's menstrual cycle.
- Compared to other fertility tests, such as basal body temperature monitoring or cervical mucus analysis, ovulation prediction kits are more convenient and less time-consuming.
- Ovulation prediction kits also boast a higher success rate in helping couples conceive. Consequently, many women prefer ovulation prediction kits over other fertility tests.
Saliva Segment Commands Sample Category Success
| Attributes |
Details |
| By Sample |
Saliva |
| Forecasted CAGR from 2024 to 2034 |
7.4% |
The market is led by the saliva segment within the sample category, a fact reinforced by the following:
- Saliva tests can be performed at home without the need for a medical professional, and they provide accurate results promptly.
- Many people prefer saliva tests over other methods, such as blood tests, because they are less invasive and can be more comfortable to perform, making saliva tests popular in the fertility market.
Analysis of Top Countries Developing, Regulating, and Utilizing Fertility Testing Solutions
| Countries |
Forecasted CAGR from 2024 to 2034 |
| United States |
7.6% |
| United Kingdom |
9.1% |
| China |
8.7% |
| Japan |
9.3% |
| South Korea |
9.8% |
Delayed Childbearing Spurs Demand for Fertility Tests in the United States
The increasing awareness among people about their reproductive health in the United States is a primary factor contributing to its dominance in the fertility test market. Other supporting factors include:
- The trend of delaying childbearing has become widespread in the United States, with many couples opting to have children later in life. Around 19% of married women aged 15 to 49 years who have not previously given birth in the United States experience difficulty getting pregnant after one year of trying. Consequently, the risk of infertility increases with age, prompting couples to turn to fertility tests to assess their chances of conceiving.
- The prevalence of lifestyle-related diseases such as obesity, diabetes, and hypertension is on the rise in the country. These conditions can negatively impact fertility, leading couples to use fertility tests to assess their risk of infertility.
- Advancements in technology have led to the development of more sophisticated and accurate fertility tests. These tests are more sensitive and can detect subtle changes in reproductive hormones, making it easier for couples to determine their fertility status.
Fertility Test Demand Grows in the United Kingdom as Lifestyle Factors Impact Reproductive Health
The fertility test market in the United Kingdom holds significant growth potential. Factors backing up this growth are:
- The National Health Service (NHS) in the United Kingdom is renowned as one of the world's largest public health systems. As per NHS statistics, about 1 in 7 couples in the United Kingdom encounter challenges when trying to conceive.
- As of the fiscal year 2022/23, over 100 fertility clinics were licensed by the Human Fertilisation and Embryology Authority (HFEA) to offer fertility treatment in the United Kingdom, contributing significantly to the growth of the fertility test market.
- The rise in lifestyle-related factors that can affect fertility. Factors such as obesity, smoking, alcohol consumption, and stress can all have a negative impact on fertility, and people are becoming increasingly aware of this. As a result, they are turning to fertility tests to assess their reproductive health and take appropriate measures to improve their chances of conception.
China's Reproductive Health Center Witnesses High Demand for Fertility Testing
The demand for fertility testing is considerable in China. This growth in the fertility test market can be attributed to the following factors:
- According to government data, China's fertility rate hit an estimated historic low of 1.09 in 2022, marking the lowest rate among countries with populations exceeding 100 million. This, in turn, increases the demand for fertility-related services.
- China's one-child policy, which was in place for several decades, has led to a significant decrease in the country's birth rate. As a result, there is growing awareness of the importance of fertility testing and treatment.
- The government has also played a crucial role in promoting fertility testing and treatment. The reproductive health center operated by the government serves hundreds of thousands of couples seeking these services.
Japan Faces Fertility Testing Surge amidst Stringent Reproductive Technology Regulations
The rise in demand for fertility tests in Japan can be attributed to the country's strict regulations on assisted reproductive technologies. In addition to this, there are several other reasons supporting the expansion of the fertility test market:
- Japan's persistently low fertility rate, hitting a record low of 1.26 in 2022, is likely to drive an increased demand for fertility tests, reflecting the societal need for comprehensive reproductive health solutions.
- Japan's stark demographic challenges, with a significant portion of women expected to remain childless, underscore the pressing need for fertility tests. This fuels a growing market driven by individuals seeking reproductive solutions.
- There are now a variety of at-home fertility testing kits available on the market in Japan, as well as more comprehensive testing options at fertility clinics.
Government Initiatives and Lifestyle Factors Drive South Korea's Fertility Test Boom
The adoption rate of fertility tests in South Korea is significantly higher than in other Asian countries, and this trend is anticipated to continue in the upcoming years. This trend is supported by:
- South Korea is struggling with the lowest global fertility rate, which dropped to 0.78 in 2022. Many couples are facing difficulties while trying to conceive, and fertility tests have become an essential tool for assessing their chances of having a child. This trend fuels a burgeoning market as individuals seek solutions for reproductive health challenges.
- The South Korean government's financial incentives for childbirth in 2022, offering up to 5 million won for families with twins, may stimulate interest in fertility tests as individuals explore options to benefit from these initiatives.
- The increasing prevalence of lifestyle factors that can affect fertility, such as stress, sedentary lifestyles, and poor diet. This has made people more conscious of their health and fertility, leading to a greater demand for fertility tests.
Leading Suppliers in the Fertility Test Sector
The fertility test market is highly competitive, with several players offering a range of products and services. These companies provide various fertility tests, ranging from prediction kits to sperm count tests. Additionally, several new players in the market are leveraging technology such as artificial intelligence and machine learning to develop advanced fertility testing solutions.
Recent Developments
- In July 2023, 2San, a reputable global leader in self-diagnostic testing, forged a partnership with Proov to roll out their exclusive, user-friendly at-home fertility tests in handpicked Hy-Vee outlets spanning eight states across the Midwest.
- In August 2023, Trajan Scientific and Medical supplied CE-IVD registered Mitra® devices to Fertilly, a German start-up that launched Europe's inaugural At-Home Fertility Test Kits employing dried blood microsampling with VAMS® technology. Fertilly's kits are medically certified and made accessible to consumers across Europe.
- In January 2022, Kindbody, a prominent provider of fertility and family-building care, unveiled Kind at Home, its consumer products division dedicated to assisting individuals throughout their complete reproductive journey. The initiative commenced with the introduction of user-friendly at-home fertility hormone tests catering to both women and men.
Notable Players in the Business Landscape
- learblue
- First Response
- Mira
- AVA
- Modern Fertility
- LetsGetChecked
- Proov
- Ovuline
- YO Home Sperm Test
- Fertility Focus
- ExSeed Health
- Sema4
- Roche
- Thermo Fisher Scientific
- Quest Diagnostics
